Pricing Log in Create free account

Opus Genetics, Inc. (IRD) vs MapLight Therapeutics, Inc. (MPLT)

Opus Genetics, Inc. and MapLight Therapeutics, Inc. are both Biotechnology companies. Opus Genetics, Inc. and MapLight Therapeutics, Inc. are of similar size ($345.7M and $333.2M). MapLight Therapeutics, Inc. has the higher net margin (0.00% vs −1,091.8%) and the lower return on invested capital (−348.4% vs 0.00%). Across the 12 metrics below, MapLight Therapeutics, Inc. leads on 7 and Opus Genetics, Inc. on 5.

Valuation

Metric IRD MPLT Biotechnology median
P/E n/m n/m 10.60
P/S 40.40 n/m 9.40
P/B n/m 0.89 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 34.95 n/m 9.02
Earnings yield (30.94%) (616.76%) (32.88%)
Free cash flow yield (10.61%) (56.19%) (23.13%)

Profitability

Metric IRD MPLT Biotechnology median
Gross margin 100.00% — 68.51%
Operating margin (513.47%) 0.00% 0.00%
Net margin (1,091.82%) 0.00% 0.00%
Free cash flow margin (412.61%) 0.00% 0.00%
Return on equity (4,796.52%) (297.18%) (51.96%)
Return on assets (163.50%) (124.79%) (46.06%)
Return on invested capital 0.00% (348.44%) 0.00%

Growth

Metric IRD MPLT Biotechnology median
Revenue growth (TTM) (36.09%) — 6.76%
EPS growth (last fiscal year) 62.79% 82.39% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric IRD MPLT Biotechnology median
Debt to equity (2.69) 0.00 0.00
Current ratio 12.19 16.52 4.97
Net debt to EBITDA 1.17 1.79 1.01

Dividend

Metric IRD MPLT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric IRD MPLT Biotechnology median
Market cap 333.20m 345.68m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack